baber/WOPTO huggingface dataset:
Patent CA-2614625-A1 (CA)
Title: A noise canceller for removing a noise component from an input speech signal
Inventor: MORII TOSHIYUKI
IPC: G10L19/12
Filed: 1997-11-06
Abstract: A random code vector reading section and a random codebook of a conventional CELP type speech coder/decoder are respectively replaced with an oscillator for outputting different vector streams in accordance with values of input seeds, and a seed storage section for storing a plurality of seeds . This makes it unnecessary to store fixed vectors as they are in a fixed codebook (ROM), thereby considerably reducing the memory capacity.
Patent CA-2616164-A1 (CA)
Title: Means and methods for analyzing a sample by means of chromatography-mass spectrometry
Inventor: HEROLD MICHAEL MANFRED
IPC: G06F19/00
Filed: 2006-07-25
Abstract: The present invention relates to a method for analyzing at least one test sample, wherein said test sample comprises at least one compound, said method comprising the steps of: a) providing at least one test sample comprising at least one compound; b) determining said at least one compound in said test sample whereby raw results are generated; and c) analyzing the raw results obtained in step b), wherein the analysis of said at least one test sample is accompanied by an analysis of at least one reference sample; and wherein the test sample and the reference sample are analyzed in an identical sequence in each step of the method. Moreover, the present invention further encompasses a system for carrying out said method comprising operatively linked to each other: (a) means for determining a compound; (b) means for monitoring process parameters, (c) means for analyzing raw results obtained from the means according to (a), wherein said means for analyzing raw results comprise: (i) a first database comprising raw results received from the means according to (a); (ii) a second database comprising monitored process parameters received from the means according to (b); (iii) a third database comprising rules for evaluating the raw results; and (iv) a fourth database comprising allocated results of identified compounds; wherein at least the second, third and fourth database are operatively linked to the first database.
Patent CA-2616234-A1 (CA)
Inventor: ZHANG YU
IPC: G06F17/27
Filed: 2007-12-21
Abstract: There is disclosed a method of facilitating interaction between users of an electronic community.  In an embodiment, the method comprises: reviewing a user activity log for each user in the electronic community; executing a natural language parser to extract significant noun phrases from the user activity log; updating user profiles from the newly extracted noun phrases, based on their usage frequency and importance value; and storing the updated profiles in a user profile and relationship data base; and executing a similarity based clustering algorithm to cluster user profiles, thereby discovering relationships among users and storing them in a user profile and relationship database. The method may further comprise displaying for each user the one or more relationships to which the user is assigned, together with a list of users assigned to the one or more relationships. The method may also comprise storing for each user the relationship to which the user is assigned in a user profile and relationship database.
Patent CA-2618661-A1 (CA)
Inventor: ZACK DAVID W
IPC: F02K1/82
Filed: 2006-07-27
Abstract: L'invention concerne un système de suppression de la signature infrarouge (IRSS), comportant un collecteur d'échappement et un conduit d'échappement à rapport d'allongement élevé dans le sens de sa longueur. Le système IRSS permet de minimiser l'impact du flux d'échappement des moteurs sur une structure d'aéronef adjacente en dirigeant ledit flux d'échappement vers le haut et/ou vers l'extérieur, à l'écart d'un fuselage et à une vitesse relativement élevée dans le but de réduire l'échauffement dudit fuselage dû au jet d'échappement en vol stationnaire ou avant, et de minimiser ainsi les contributions de la signature infrarouge sur le fuselage. Le fait de diriger le flux d'échappement vers le haut permet en outre de bloquer le trajet optique direct vers l'énergie infrarouge évacuée vis-à-vis de menaces au sol. Le conduit d'échappement à rapport d'allongement élevé et le collecteur d'échappement sont de préférence protégés par un carénage aérodynamique qui forme un contour aérodynamique conçu pour minimiser l'impact aérodynamique sur l'aéronef et qui définit un espace d'éjection refroidi par air susceptible d'accroître l'écoulement d'air en isolant et en masquant ainsi davantage les gaz d'échappement à haute température évacués par le conduit d'échappement.
Patent CA-2620177-A1 (CA)
Inventor: KIM YOUNG-KEUN
IPC: G06F15/16
Filed: 2006-09-12
Abstract: A mobile node transmits a frame requesting IP address allocation information needed to obtain an IP address in a neighboring network; receives a frame including the IP address allocation information requested in the transmitted frame; and obtains an IP address in the neighboring network based on the IP  address allocation information in the received frame to move to the neighboring network.
Patent CA-2621463-A1 (CA)
Inventor: BRENNAN ROBERT CHRYSLER
IPC: F03H1/00
Filed: 2006-08-25
Abstract: The present invention provides method, apparatus, and system that generates and uses a motive and other force by introducing a plasma environment into an asymmetric capacitor, resulting in a significant gain in force. In one embodiment, the energy field is energized by applying a system to increase a plasma density by ionizing the plasma environment in the energy field through electromagnetic radiation, by increasing the plasma temperature, or some combination thereof. The invention also generates a flow of energy or plasma directed outward from the apparatus. The present invention can also provide the motive forces at a variety of angles at substantially reduced voltage levels.
Patent CA-2621973-A1 (CA)
Inventor: ROSEN MICHAEL R
IPC: A61K31/713
Filed: 2006-09-11
Abstract: This invention provides a chimeric hyperpolarization-activated, cyclic nucleotide-gated (HCN) polypeptide comprising portions of more than one type of HCN channel. The invention also provides methods of treating a subject afflicted with a cardiac rhythm disorder comprising expression of the chimeric HCN polypeptide in a selected region of the heart so as to induce a pacemaker current in the heart and thereby treat the subject.
Patent CA-2623126-A1 (CA)
Inventor: CORDING CHRISTOPHER R
IPC: E04C2/54
Filed: 2006-09-20
Abstract: The energy-free refrigeration door of the present application provides a way to control condensation when the door of a refrigeration unit is opened by providing thermal insulation to the door with glass panels which have a low emissivity coating. The door includes a door frame housing and an insulating glass unit comprising inner, middle and outer sheets of glass. A first sealant assembly disposed around the periphery of the inner and middle sheets of glass forms a first chamber between the inner and middle sheets of glass. A second sealant assembly disposed around the periphery of the middle and outer sheets of glass forms a second chamber between the middle and outer sheets of glass.  A gas, such as krypton, air, or argon is held in the first and second chambers. The outer sheet of glass and inner sheet of glass each have an unexposed surface that faces the middle sheet of glass. A low emissivity coating is disposed on the unexposed surfaces of the inner and outer sheets of glass so that the glass door as a whole avoids formation of condensation on the outer surface of the outer sheet of the glass door, without the application of electricity to heat the door, while also providing the desired evaporation rate of condensation from the inner side of the inner sheet of the glass door. An anti-fog or anti-frost coating is included on a surface of one of the sheets of glass.
Patent CA-2623326-A1 (CA)
Title: Amino-alkyl-amide derivatives as ccr3 receptor ligands
Inventor: VARGA MARTON
IPC: C07D235/28
Filed: 2006-09-21
Abstract: The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I) and their salts, solvates and isomers and to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers.
Patent CA-2626748-A1 (CA)
Inventor: FOLKVANG JORN
IPC: B01D17/025
Filed: 2006-10-27
Abstract: A gravity separator comprises a vessel within which a mixture containing water, oil, and gas can separate under gravity to form vertically discrete oil and water layers and a gas phase. An inlet duct communicates with a vessel entrance for the mixture containing water, oil, and gas. The inlet duct of the gravity separator comprises injector means injecting a gaseous medium in a volume in the range of 0.01-1.9 Sm3 gaseous medium per 1m3 mixture into the mixture containing water, oil, and gas.
Patent CA-2626901-A1 (CA)
Title: Methods for manufacturing dental implant components
Inventor: ROGERS DAN P
IPC: A61C1/00
Filed: 2006-10-19
Abstract: A method of manufacturing a rapid prototype overmold for locating a dental implant analog in a modified stone model for use in creating a tooth prosthesis is provided. An impression of a mouth having a first installation site that has a dental implant and a gingiva healing abutment with at least one informational marker installed is taken. A  stone model based on the impression is prepared. The model is scanned. A three-dimensional computer model of the installation site on a CAD program using data from the scan is created. The-at least one informational marker is determined to gather information about the location of the dental implant. Abutment dimensional information based on the three-dimensional model and the at least one informational marker is developed. Rapid prototype overmold dimensional information based on the three-dimensional model is developed. The rapid prototype overmold adapted to fit over the modified stone model is fabricated.
Patent CA-2627280-A1 (CA)
Title: Adapter
Inventor: LAROCQUE PIERRE-ANDRE
IPC: F21V19/00
Filed: 2008-03-26
Abstract: The present invention provides an adapter allowing them to be installed into a lamp fixture primilarly conceived for fluorescent tubes. Certain types of neon tubes consume significantly less electricity while operating than fluorescent tubes and have a longer lifetime than fluorescent tubes. The adapter comprises a pin holder from which one or more pins extend and has means to electrically connect the electrode of the neon tube to the lamp fixture. An adapter is installed on each extremity of a neon tube prior to the installation of the neon tube in a modified fluorescent lamp fixture. Finally, neon tubes do not comprise or at the very least comprise significantly less mercury (which is widely recognized as being a health treat) than is found in fluorescent tubes.
Patent CA-2627497-A1 (CA)
Inventor: KAIEDA AKIRA
IPC: C07D239/90
Filed: 2006-10-27
Abstract: Disclosed is a novel amide derivative represented by the formula below (wherein the symbols are as defined in the description). This amide derivative has a matrix metalloproteinase inhibitory activity, and is useful as a pharmaceutical product.
Patent CA-2627588-A1 (CA)
Title: Pharmaceutical combination
Inventor: BANSAL VINAY S
IPC: A61K31/40
Filed: 2006-11-08
Abstract: This invention relates to a combination product or medicament comprising at least one novel substituted pyrrole derivative and one or more dyslipidemic agents, antiobesity agents, antihyperglycaemic agents, anti-inflammatory agents or mixture thereof. Also provided herein are the pharmaceutical compositions comprising at least one novel substituted pyrrole derivative and one or more dyslipidemic agents, antiobesity agents, antihyperglycaemic agents, anti-inflammatory agents or mixture thereof and optionally together with at least one pharmaceutically acceptable carrier, and methods for the treatment or prophylaxis of cardiovascular diseases, Alzheimer's disease, obesity, diabetes or inflammatory diseases comprising administering to a mammal in need thereof therapeutically effective amounts of combination pharmaceutical composition comprising at least one novel substituted pyrrole derivative and one or more dyslipidemic agents, antiobesity agents, antihyperglycaemic agents, anti-inflammatory agents or mixtures thereof.
Patent CA-2629405-A1 (CA)
Title: Tissue engineering methods and compositions
Inventor: ESTES BRADLEY T
IPC: A61K35/28
Filed: 2006-09-11
Abstract: The presently disclosed subject matter generally relates to methods and systems for facilitating the growth and differentiation of adipose-derived stem cells for laboratory and therapeutic applications. The cells can be employed alone or in conjunction with unique biologically-compatible scaffold structures to generate differentiated tissues and structures, both in vitro and in vivo. The presently disclosed subject matter further relates to methods of forming and using improved tissue engineered scaffolds that can be used as substrates to facilitate the growth and differentiation of cells.
Patent CA-2630306-A1 (CA)
Title: Method and apparatus for analyte data telemetry
Inventor: BRUCE ROBERT
IPC: A61N1/00
Filed: 2006-11-20
Abstract: Embodiments of the present invention provide methods and apparatuses for telemetry, more specifically, methods and apparatuses for providing telemetry in association with medical devices. Exemplary embodiments of the present invention provide continuous telemetry between a transmitter and a monitoring unit, for example in a medical monitoring environment.
Patent CA-2633118-A1 (CA)
Title: Alxgayin1-x-yn crystal substrate, semiconductor device, and method of manufacturing the same
Inventor: OKUI MANABU
IPC: H01L21/20
Filed: 2006-10-16
Abstract: This invention provides an AlxGayIn1-x-yN crystal substrate (12) having a main plane (12m) having an area of not less than 10 cm2. The main plane (12m) has an outer area (12w) which is within 5 mm from the outer periphery and an inner area (12n) which is an area other than the outer area. The inner area (12n) has a total dislocation density of not less than 1 ~ 102 cm-2 and not more than 1 ~ 106 cm-2. The above constitution can provide an AlxGayIn1-x-yN  crystal substrate as a semiconductor device, which is large and has suitable dislocation density, a semiconductor device comprising the AlxGayIn1-x-yN  crystal substrate, and a method for manufacturing the same.
Patent CA-2634476-A1 (CA)
Inventor: STIMSON MARTIN L
IPC: E01C19/02
Filed: 1999-02-15
Abstract: An asphalt plant including a plurality of asphalt processing components, with a selected first set of the components producing volatile emissions and a selected second set requiring process heat energy. A central burner assembly is connected to the selected second set of components by an insulated duct system for providing heat energy to the second component set. A first duct system is adapted to capture a portion of the volatile emissions produced by the first component set and convey the captured emissions into the central burner for mitigation. The central burner is preferably a media burner incorporating flameless combustion technology as well as an adjustable internal fuel injection system, which results in safer and more controllable combustion. Even with captured fugitive emissions in the inlet air, the fuel injection system keeps the concentration of combustible materials well below the lower flammability limit.
Patent CA-2636102-A1 (CA)
Inventor: FLAGG MICHAEL F
IPC: B65D5/48
Filed: 2007-01-03
Abstract: A partition insert (100) includes a longitudinal primary partition panel (12), transverse divider panels (14, 16, 18, 20, 22), and a locking flap (26). The divider panels (14, 16, 18, 20, 22) are rotated to an operative position and the locking flap (26) is rotated toward the primary partition panel (12). The partition insert includes means for engaging (52) such that the divider panels (14, 16, 18, 20, 22) and the locking flap (26) can engage one another to fix the position of the divider panels (14, 16, 18, 20, 22) in the operative position.
Patent CA-2637153-A1 (CA)
Title: Training and fitness apparatus
Inventor: SUMMERS NEIL
IPC: A63B71/08
Filed: 2008-07-09
Abstract: The present invention provides for exercise apparatus which can comprise general fitness or self-defence training apparatus (10) having a base member (12); means arranged to define a first elongate member (18) and a second elongate member (20) extending upwardly therefrom; the first elongate member (18) and the second elongate member (20) being joined at, or by way of a target portion (24); wherein the base member (12) is weighted relative to the elongate members (18,20) and the target portion (24) so as to seek to keep the elongate members (18,20) in a substantially upright position.
Patent CA-2638429-A1 (CA)
Inventor: KWASNY HENRY A
IPC: F16G11/05
Filed: 2008-07-28
Abstract: A tool and a method are provided for splaying strands of a wire rope at an end thereof. The tool features a body defining a central opening and a plurality of outer openings extending into the body from a common side thereof, the openings sized and positioned for receipt of end portions of the strands at the end of the wire rope. The outer openings are arranged for splaying of the strands of the rope outward away from the core thereof under rotation of the body in a first direction about the core with the strands received in the openings. The rotation untwists the strands from around the core while the openings are shaped to limit motion of the untwisted ends of the strands to sliding motion along guiding surfaces outward away from the core.
Patent CA-2647445-A1 (CA)
Title: N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
Inventor: COLOMBO ANDREA
IPC: A61K31/5375
Filed: 2007-03-30
Abstract: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH-NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.
Patent CA-2648836-A1 (CA)
Inventor: DEYINE ABDALLAH
IPC: A61P25/28
Filed: 2008-12-31
Abstract: Composés de formule (I) : (voir formule I) dans laquelle : - R1 et R2, identiques ou différents, représentent un atome d'hydrogène ou u n groupement alkyle (C1-C6) linéaire ou ramifié, - R3 représente un atome d'hydrogène ou d'halogène, un groupement alkyle (C1 - C6) linéaire ou ramifié, ou un groupement alkoxy (C1-C6) linéaire ou ramifié, - Het représente un groupement pyridyle, pyrimidyle ou pipéridyle, éventuellement substitués par un ou plusieurs groupements choisis parmi halogène, alkyle (C 1- C6) linéaire ou ramifié, alkoxy (C1-C6) linéaire ou ramifié, - ~ représente une liaison simple ou une liaison double, leurs énantiomères et diastéréoisomères, ainsi que leurs sels d'addition à u n acide ou à une base pharmaceutiquement acceptable, Médicaments.
Patent CA-2651176-A1 (CA)
Title: Deflectable sheath handle assembly
Inventor: POPOWSKI JEFFREY A
IPC: A61M25/01
Filed: 2007-05-03
Abstract: A deflectable catheter assembly includes a deflectable body manipulatable by a rotating actuator of a housing assembly. The housing assembly includes a sliding member having a threaded portion including a first threaded portion having a first pitch and a second threaded portion having a second pitch, where the first pitch is different than the second pitch.
Patent CA-2654415-A1 (CA)
Inventor: CALOS MICHELLE P
IPC: C12N15/90
Filed: 2007-05-22
Abstract: The subject invention provides a site-specific integration system and methods for generating eukaryotic cells lines for protein production. The provided system includes a first site-specifically integrating target vector and a second site- specifically integrating donor vector comprising a gene of interest. Also provided are mammalian cell lines produced by the subject methods and systems, as well as kits that include the subject systems.
Patent CA-2654912-A1 (CA)
Title: Oxygen injection method
Inventor: DENEYS ADRIAN CHRISTIAN
IPC: C21C5/52
Filed: 2007-06-26
Abstract: A method of injecting oxygen into a melt located within a metallurgical furnace having a heated furnace atmosphere in which oxygen and fuel is injected into 1 or more nozzles having passageways of converging- diverging configuration under choked flow conditions to produce supersonic jet or jets discharged from the passageways. Fuel is injected into internal circumferential locations of the passageways so as to impart a structure to the jets being discharged that have an outer circumferential region containing a mixture of fuel and oxygen and a central region containing essentially oxygen. Such a structured jet upon discharge interacts with the furnace atmosphere to create an outer shear-mixing zone in which the outer circumferential layer mixes with the heated furnace atmosphere and auto- ignites to produce a flame envelope surrounding a supersonic jet of oxygen. The jet of oxygen and flame envelope can be directed against a melt contained within the metallurgical furnace for injection of oxygen into the melt.
Patent CA-2655922-A1 (CA)
Inventor: KREUZER THOMAS
IPC: F01N3/08
Filed: 2007-06-05
Abstract: Nitrogen oxide storage catalysts are used for removal of nitrogen oxides present in the lean exhaust gas of so-called lean-burn engines. Storage catalysts are thermally modified at high temperatures. The modification is a sintering of the catalytically active noble metal components of the catalyst and a formation of compounds of the storage components with the support materials. According to the invention, the formation of compounds of the storage materials can be largely reversed by treatment of the storage material with a gas mixture containing carbon dioxide, optionally steam and optionally nitrogen oxide at temperatures between 200 °C and 950 °C, preferably between 300 °C and 700 °C. The reactivation can be carried out with neutral emissions directly in the vehicle during operation by the adjustment of suitable exhaust conditions and regulating the fuel/air mixture.
Patent CA-2656720-A1 (CA)
Inventor: GOOSSENS DANIELLE F
IPC: D06M11/58
Filed: 2007-07-05
Abstract: Textile products having a flame retarded coating wherein the flame retarded coating contains as a flame-retarding agent a composition comprising N-2,3-Dibromo.rho.ropyl-4,5- dibromohexahydrophthalimide.
Patent CA-2657329-A1 (CA)
Inventor: ECHIGO MITSUAKI
IPC: C01B32/50
Filed: 2002-03-25
Abstract: Divulgation d'une technique d'extraction du monoxyde de carbone, de façon stable pendant une longue période, pendant le fonctionnement d'un réacteur d'élimination du monoxyde de carbone ou d'un système de reformage de combustible. Dans une méthode, l'élimination du monoxyde de carbone comprend : une première étape d'introduction d'un réactif gazeux, contenant un mélange de gaz et un oxydant, dans un réacteur d'élimination du monoxyde de carbone comportant dans son enveloppe une couche de catalyseur constituée d'un catalyseur pour l'élimination du monoxyde de carbone contenu dans le mélange gazeux : une deuxième étape d'élimination du monoxyde de carbone par réaction de l'oxydant avec le mélange de gaz sur le catalyseur. Lors de la première étape, le réactif gazeux est introduit dans le réacteur d'élimination du monoxyde de carbone à 100 oC ou moins.